Boston Scientific Corporation
BSX
주식 순위
#409
이 기업 소개는 영어로만 제공됩니다.
Boston Scientific Corporation (BSX) operates as a global leader in medical... Boston Scientific Corporation (BSX) operates as a global leader in medical technology, specializing in the design, manufacturing, and commercialization of innovative medical devices tailored for a diverse array of interventional medical specialties across the globe. Its business is strategically organized into three principal segments: MedSurg, Rhythm and Neuro, and Cardiovascular. Within these divisions, the company provides a comprehensive portfolio of solutions addressing various gastrointestinal and pulmonary ailments, as well as urological and pelvic health concerns. This extends to advanced implantable devices for managing cardiac rhythm disorders, such as cardioverter-defibrillators, cardiac resynchronization therapy devices, and pacemakers, complemented by remote patient management systems. Furthermore, Boston Scientific offers sophisticated technologies for diagnosing and treating complex heart rate and rhythm irregularities. These encompass 3-D cardiac mapping and navigation tools, along with a suite of specialized catheters (including ablation, diagnostic, mapping, and intracardiac ultrasound types), delivery sheaths, and related accessories. Its offerings also extend to neurological conditions, providing spinal cord stimulator systems for chronic pain management, indirect decompression systems, and deep brain stimulation systems. In the realm of interventional cardiology, the company's innovations include drug-eluting coronary stent systems designed for treating coronary artery disease, products for percutaneous coronary interventions to combat atherosclerosis, and intravascular imaging catheters (such as ultrasound and fractional flow reserve devices) for assessing coronary arteries, heart chambers, and peripheral vessels. It also develops structural heart therapies. Beyond this, Boston Scientific supplies an array of stents, balloon catheters, wires, and atherectomy systems for the treatment of arterial diseases. For venous conditions, it provides thrombectomy and acoustic pulse thrombolysis systems, alongside wires and stents. Critically, the company also contributes to cancer treatment through peripheral embolization devices, radioactive microspheres, various ablation systems (including cryotherapy), and micro and drainage catheters. The organization was established in 1979 and maintains its corporate headquarters in Marlborough, Massachusetts.
주가
$41.88
마지막 동기화: 2026-10-30
시가총액
$60.69B
변동 (1일)
-1.89%
변동 (1년)
-58.42%
국가
US
주식 데이터: Financial Modeling Prep·업데이트: ·투자 조언이 아닙니다·계산 방식
거래 Boston Scientific Corporation (BSX)
카테고리
Healthcare
Boston Scientific Corporation (BSX)의 수익
Sep 2026 기준 수익 TTM: $3.66B
Boston Scientific Corporation의 최신 재무 보고서에 따르면 회사의 현재 수익은 $3.66B입니다. 2025년에 회사는 $3.39B의 수익을 올렸으며 이는 2024년의 수익 $2.28B과 증가입니다. 이 페이지에 표시된 수익은 이자 및 세금 공제 전 수익으로, 즉 EBIT입니다.
Boston Scientific Corporation의 수익 기록 (2000 ~ 2026)
연말 수익
| 연도 | 수익 | 변화 |
|---|---|---|
| 2026 (TTM) | $3.66B | 7.98% |
| 2025 | $3.39B | 48.33% |
| 2024 | $2.28B | 14.96% |
| 2023 | $1.99B | 73.97% |
| 2022 | $1.14B | 6.04% |
| 2021 | $1.08B | -1,462.03% |
| 2020 | $-79.00M | -111.50% |
| 2019 | $687.00M | -51.69% |
| 2018 | $1.42B | 52.41% |
| 2017 | $933.00M | 427.12% |
| 2016 | $177.00M | -127.23% |
| 2015 | $-650.00M | 27.70% |
| 2014 | $-509.00M | 128.25% |
| 2013 | $-223.00M | -94.57% |
| 2012 | $-4.11B | -739.72% |
| 2011 | $642.00M | -160.40% |
| 2010 | $-1.06B | -18.73% |
| 2009 | $-1.31B | -35.60% |
| 2008 | $-2.03B | 256.94% |
| 2007 | $-569.00M | -83.90% |
| 2006 | $-3.54B | -496.75% |
| 2005 | $891.00M | -40.36% |
| 2004 | $1.49B | 132.35% |
| 2003 | $643.00M | 17.12% |
| 2002 | $549.00M | 1,147.73% |
| 2001 | $44.00M | -91.65% |
| 2000 | $527.00M | 0.00% |
유사 기업 또는 경쟁사의 수익
| 회사 | 수익 | 수익 차이 | 국가 |
|---|---|---|---|
| $6.56B | 79.53% |
US
|
|
| $6.60B | 80.66% |
IE
|
|
| $5.12B | 39.97% |
US
|
|
| $3.23B | -11.70% |
DE
|
|
| $1.42B | -61.21% |
US
|
Boston Scientific Corporation 순이익 관련 질문
Boston Scientific Corporation 순이익, 현재 얼마인가요?
2026년 9월 기준 최근 12개월 Boston Scientific Corporation 순이익: $3.66B.
2025년 Boston Scientific Corporation 순이익, 얼마였나요?
2025년 Boston Scientific Corporation 순이익: $3.39B. 2024년($2.28B)보다 48.33% 높은 수치입니다.
2020년 이후 Boston Scientific Corporation 순이익, 어떻게 변했나요?
2020년부터 2025년까지 Boston Scientific Corporation 순이익 최고치는 2025년($3.39B), 최저치는 2020년($-79.00M)이었습니다.
Boston Scientific Corporation 순이익, 유사 기업과 비교하면 어떤가요?
Boston Scientific Corporation 순이익 수치($3.66B)는 위에 나온 유사 기업 5곳 중 2곳보다 높습니다. 이 중 가장 높은 곳은 Medtronic plc($6.60B)입니다.